Increased body weight and decreased expansion of pro-inflammatory CD4+ T-cells from blood in Tg-HD5 rats. by Osiris Marroquin Belaunzaran (224031)

<i>L. monocytogenes</i> causes LLO-mediated downregulation of CD117 but not FcεRI on BMMC and decreases chemotaxis. by Catherine E. Jobbings (382681)

Treatment of cancer cells with FL118 significantly decreases BrdU positive cells (proliferative cells) and induces apoptotic markers. by Xiang Ling (307318)

MSC treatment promoted an increase in homeostatic macrophage- (CD206⁺) and a decrease in pro-inflammatory cells (iNOS⁺), and reduced fibrosis in osteoarthriti... by Amanda M. Hamilton (8072207)

Determining the role of missense mutations in the POU domain of HNF1A that reduce the DNA-binding affinity: A computational approach by Sneha P. (3926957)

“…Triplicate runs of molecular dynamic (MD) simulations (50ns) revealed smaller changes in patterns of deviation, fluctuation, and compactness, in complexes containing the R131Q and R131W mutations, compared to complexes containing the R203C mutant complex. …”

PPARα expression was decreased in aged and photoaged human skin and in UV-irradiated skin <i>in vivo</i> and in dermal fibroblasts. by Mi Hee Shin (406400)

Summary of the effect of MPDD on ART and TIBL across all participants, and also participants categorized by driving styles (“NS” (no significant), “+” (significant increase), and “... by Mobina Faqani (22783963)

The IC50 value of Tan in normal esophageal HET-1A cells. by Dong Yang (141041)

Total discounted value of savings in 2012 for a reduction in CVD incidence to decrease mortality by 25% by 2025 “incidence-based” scenario (billions of 2012C$). by David Boisclair (4734936)

Graphic representation of the definition of the index of variation of intracycle velocity (VIV_Index). by Marek Rejman (9199616)

Hospitalized persons for different calibration runs compared to real data. by Sebastian A. Müller (10688740)

Stable isotope biplots of end-members (colored points) faceted by coastscape and overlayed consumers (gray points). by Nathan D. McTigue (10706460)

Fourteen days after tMCAo surgery mice with RNS60 treatment show a decrease in microglial activation Iba1 (+) in the CA3 region of the ipsilateral hippocampus. by Gloria Patricia Baena-Caldas (17721328)

C2GnT1 gene knockdown decreases C2-O-sLe^X glycoproteins and C2GnT1 activity. by Catherine A. St. Hill (357388)

“…Note the absence of a detected C2GnT1 protein 50 kDa band. (D) We observed a 30–40% decrease in reactivity with CHO-131 mAb by flow cytometry for LS174T and HepG2 cells that contained C2GnT1 shRNA. …”

Top Genes with Significantly Decreased Transcript Levels Systemically During SSTI¹. by Rebecca A. Brady (408084)

“…<p>¹All genes that had a significantly decreased LFC when comparing uninfected ears from challenged mice to naïve mice are listed.…”

Differential gene expression assay EC₅₀ values in Huh-7 cells and PHH. by Xuan G. Luong (9761423)

Advancing the science of NOWS research. by Sarah E. Maylott (14560785)

“…It is not known which infants will develop NOWS, therefore, the current hospital standard-of-care dictates a 96-hour observational hold. Understanding which infants will develop NOWS soon after birth could reduce hospital stays for infants who do not develop NOWS and decrease burdens on hospitals and clinicians. …”

Protocol measures. by Sarah E. Maylott (14560785)

“…It is not known which infants will develop NOWS, therefore, the current hospital standard-of-care dictates a 96-hour observational hold. Understanding which infants will develop NOWS soon after birth could reduce hospital stays for infants who do not develop NOWS and decrease burdens on hospitals and clinicians. …”

Cry variables. by Sarah E. Maylott (14560785)

“…It is not known which infants will develop NOWS, therefore, the current hospital standard-of-care dictates a 96-hour observational hold. Understanding which infants will develop NOWS soon after birth could reduce hospital stays for infants who do not develop NOWS and decrease burdens on hospitals and clinicians. …”

Phosphorylation as an Effective Tool to Improve Stability and Reduce Toxicity of Antimicrobial Peptides by Zufang Ba (11036420)

“…Phosphorylation can reduce toxicity and improve the stability of AMPs. Based on these, we designed a series of peptides and their corresponding phosphorylated forms. …”